Dr. Rai Discusses CLL in Older Populations

Kanti R. Rai, MD
Published: Tuesday, Nov 21, 2017



Kanti R. Rai, MD, professor, The Karches Center for Oncology Research, The Feinstein Institute for Medical Research, director, Center for Oncology and Cell Biology, Long Island Jewish Medical Center, professor, Medicine and Molecular Medicine, Hofstra Northwell School of Medicine, discusses older populations with chronic lymphocytic leukemia (CLL).

Treatment should be individualized for patients with CLL, and not based solely on age, says Rai. A patient who is 65 may be as healthy as a 50-year-old, or as frail as someone much older.


Kanti R. Rai, MD, professor, The Karches Center for Oncology Research, The Feinstein Institute for Medical Research, director, Center for Oncology and Cell Biology, Long Island Jewish Medical Center, professor, Medicine and Molecular Medicine, Hofstra Northwell School of Medicine, discusses older populations with chronic lymphocytic leukemia (CLL).

Treatment should be individualized for patients with CLL, and not based solely on age, says Rai. A patient who is 65 may be as healthy as a 50-year-old, or as frail as someone much older.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x